Eculizumab and aHUS: to stop or not

Robert A. Brodsky

doi:10.1182/blood.2020010234

Eculizumab and aHUS: to stop or not

School of Medicine

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	2419-2420
Number of pages	2
Journal	Blood
Volume	137
Issue number	18
DOIs	https://doi.org/10.1182/blood.2020010234
State	Published - May 6 2021

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood.2020010234

Cite this

@article{b0c48b7ca2224e47a2da2af01cff58e8,

title = "Eculizumab and aHUS: to stop or not",

author = "Brodsky, {Robert A.}",

year = "2021",

month = may,

day = "6",

doi = "10.1182/blood.2020010234",

language = "English (US)",

volume = "137",

pages = "2419--2420",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

number = "18",

}

TY - JOUR

T1 - Eculizumab and aHUS

T2 - to stop or not

AU - Brodsky, Robert A.

PY - 2021/5/6

Y1 - 2021/5/6

UR - http://www.scopus.com/inward/record.url?scp=85105322723&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85105322723&partnerID=8YFLogxK

U2 - 10.1182/blood.2020010234

DO - 10.1182/blood.2020010234

M3 - Editorial

C2 - 33956069

AN - SCOPUS:85105322723

SN - 0006-4971

VL - 137

SP - 2419

EP - 2420

JO - Blood

JF - Blood

IS - 18

ER -

Eculizumab and aHUS: to stop or not

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this